Table 1.
Characteristic | Home discharge | Non-home discharge | Univariate OR (95% CI) | p Value |
---|---|---|---|---|
n=512 | n=75 | |||
Age, y, mean (SD) | 62.2 (11.3) | 74.8 (7.4) | 3.46 (2.54, 4.71)* | <0.001 |
BMI, kg/m2, n (%) | 0.43 | |||
Underweight/normal (<24.9) | 186 (36.5) | 27 (36.0) | Reference | |
Overweight (25.0–29.9) | 163 (32.0) | 18 (24.0) | 0.76 (0.40, 1.43) | |
WHO class I (30.0–34.9) | 89 (17.4) | 17 (22.7) | 1.32 (0.68, 2.54) | |
WHO class II or III (35.0+) | 72 (14.1) | 13 (17.3) | 1.24 (0.61, 2.54) | |
ECOG performance status, n (%) | <0.001 | |||
0 | 396 (77.5) | 37 (49.3) | Reference | |
1 | 86 (16.8) | 16 (21.3) | 1.99 (1.06, 3.74) | |
2+ | 29 (5.7) | 22 (29.3) | 8.12 (4.25, 15.53) | |
ASA score, n (%) | <0.001 | |||
<3 | 296 (57.8) | 16 (21.3) | Reference | |
≥3 | 216 (42.2) | 59 (78.7) | 5.05 (2.83, 9.02) | |
Medical comorbidities, n (%) | ||||
Cardiac event† | 37 (7.2) | 15 (20.0) | 3.21 (1.66, 6.19) | <0.001 |
Cardiovascular risk factors‡ | 284 (55.5) | 60 (80.0) | 3.21 (1.78, 5.80) | <0.001 |
DVT/PE | 35 (6.8) | 10 (13.3) | 2.10 (0.99, 4.44) | 0.05 |
Diabetes | 43 (8.4) | 15 (20.0) | 2.73 (1.43, 5.20) | 0.002 |
COPD | 19 (3.7) | 7 (9.3) | 2.67 (1.08, 6.59) | 0.03 |
Other pulmonary disease§ | 57 (11.1) | 9 (12.0) | 1.09 (0.52, 2.30) | 0.82 |
Smoking history, n (%) | 0.97 | |||
No | 315 (61.5) | 46 (61.3) | Reference | |
Yes (past or current) | 197 (38.5) | 29 (38.7) | 1.01 (0.61, 1.66) | |
Hemoglobin, g/dL, mean (SD) | 12.9 (1.4) | 12.2 (1.5) | 0.75 (0.63, 0.88) | <0.001 |
Creatinine, mg/dL, mean (SD) | 0.9 (0.2) | 1.0 (0.3) | 3.17 (1.33, 7.54) | 0.009 |
Albumin, g/dL, mean (SD) | 3.9 (0.5) | 3.5 (0.6) | 0.27 (0.16, 0.46) | <0.001 |
Thrombocytosis, n (%)|| | 108 (21.5) | 21 (28.0) | 1.42 (0.82, 2.46) | 0.21 |
CA-125, U/mL, median (IQR) | 849 (462, 2700) | 481 (135, 1385) | 1.18 (1.06, 1.30)* | 0.002 |
Percentages based on non-missing values.
ASA, American Society of Anesthesiologists; BMI, body mass index, CI, confidence interval; COPD, chronic obstructive pulmonary disease; DVT/PE, deep vein thrombosis/pulmonary embolism; ECOG, Eastern Cooperative Oncology Group; OR, odds ratio; PVD, peripheral vascular disease; SD, standard deviation; WHO, World Health Organization; IQR, interquartile range.
Odds ratio for age per 10-y increment and per doubling for CA-125.
Cardiac event represents patients with a history of coronary artery disease, myocardial infarction or other cardiac event.
Cardiovascular risk factors represent patients with a history of hypertension, hyperlipidemia or peripheral vascular disease.
Other pulmonary disease represents patients with asthma, sleep apnea, or other pulmonary diagnoses.
Thrombocytosis defined as preoperative platelet count >450 × 109/L.